James Healy's Net Worth

$17.1 Million

Who is James Healy?

James Healy has an estimated net worth of $17.1 Million. This is based on reported shares across multiple companies, which include Natera, Inc., ArriVent Biopharma, Inc., , AMARIN CORP PLC\UK, COTHERIX INC, Trius Therapeutics Inc, HYPERION THERAPEUTICS INC, Y-mAbs Therapeutics, Inc., MARINUS PHARMACEUTICALS INC, HISTOGENICS CORP, Vera Therapeutics, Inc., Aclaris Therapeutics, Inc., Karuna Therapeutics, Inc., Aerovate Therapeutics, Inc., AERIE PHARMACEUTICALS INC, Coherus BioSciences, Inc., Edge Therapeutics, Inc., Inozyme Pharma, Inc., KALOBIOS PHARMACEUTICALS INC, Entasis Therapeutics Holdings Inc., Iterum Therapeutics plc, Checkmate Pharmaceuticals, Inc., Galera Therapeutics, Inc., Bolt Biotherapeutics, Inc., Principia Biopharma Inc., NextCure, Inc., Mirna Therapeutics, Inc., THRESHOLD PHARMACEUTICALS INC, aTYR PHARMA INC, ALIMERA SCIENCES INC, Akouos, Inc., NOVACEA INC, Durata Therapeutics, Inc., Versartis, Inc., Anthera Pharmaceuticals Inc, Spark Therapeutics, Inc., Ocera Therapeutics, Inc., ANESIVA, INC., INTERMUNE INC, and Rapport Therapeutics, Inc..

SEC CIK

James Healy's CIK is 0001245624

Past Insider Trading and Trends

2022 was James Healy's most active year for acquiring shares with 14 total transactions. James Healy's most active month to acquire stocks was the month of April. 2014 was James Healy's most active year for disposing of shares, totalling 15 transactions. James Healy's most active month to dispose stocks was the month of December. 2022 saw James Healy paying a total of $951,227.38 for 200,024 shares, this is the most they've acquired in one year. In 2024 James Healy cashed out on 61,394 shares for a total of $16,984,679.20, their largest year based on trade value.